Related Experiment Videos
[Plasma prolactin levels and pubertal gynecomastia]
Summary
Boys with pubertal gynecomastia showed higher prolactin levels, but no hyperprolactinemia was found. These findings challenge the theory linking prolactin to gynecomastia development.
Area of Science:
- Endocrinology
- Pediatrics
Background:
- Pubertal gynecomastia is common in adolescent boys.
- The role of prolactin in gynecomastia development remains unclear.
Purpose of the Study:
- To investigate the relationship between prolactin levels and pubertal gynecomastia in boys.
- To assess the effect of thyrotropin-releasing hormone (TRH) stimulation on prolactin levels in boys with gynecomastia.
Main Methods:
- Measured serum prolactin levels in 23 boys with pubertal gynecomastia and compared them to controls.
- Administered TRH stimulation tests to assess prolactin response.
- Observed the effects of bromocriptine therapy in boys with mammary secretion.
Main Results:
- Boys with gynecomastia had higher mean prolactin levels (10.1 ng/ml) than controls (6.2 ng/ml).
- No cases of hyperprolactinemia were identified, even after TRH stimulation.
- Bromocriptine therapy successfully halted mammary secretion, and prolactin levels remained unresponsive to stimulation during treatment.
Conclusions:
- Elevated prolactin levels in boys with pubertal gynecomastia do not indicate hyperprolactinemia.
- The study's findings contradict the hypothesis that prolactin is a causative factor in pubertal gynecomastia.